Showing results (11-20 of 59) with videos related to

Sort By:
Pageof 6
Cytokine & Growth Factor Reviews|July 27, 2015
Emerging roles for IL-11 signaling in cancer development and progression: Focus on breast cancerCameron N Johnstone, Ashwini Chand, Tracy L Putoczki, et al.
Acta Crystallographica. Section D, Biological Crystallography|September 9, 2014
The structure of human interleukin-11 reveals receptor-binding site features and structural differences from interleukin-6Tracy L Putoczki, Renwick C J Dobson, Michael D W Griffin
Oncotargets and Therapy|February 2, 2019
Ponatinib: a novel multi-tyrosine kinase inhibitor against human malignanciesFiona H Tan, Tracy L Putoczki, Stanley S Stylli, et al.
Journal of Gastroenterology and Hepatology|January 27, 2016
Mouse models for gastric cancer: Matching models to biological questionsAshleigh R Poh, Robert J J O'Donoghue, Matthias Ernst, et al.
Current Drug Targets|November 21, 2014
The role of STAT3 signaling in mediating tumor resistance to cancer therapyFiona H Tan, Tracy L Putoczki, Stanley S Stylli, et al.
Seminars in Immunology|January 18, 2014
Epithelial gp130/Stat3 functions: an intestinal signaling node in health and diseaseMatthias Ernst, Stefan Thiem, Paul M Nguyen, et al.
Immunology and Cell Biology|May 4, 2016
Th17 cell differentiation proceeds independently of IRF8Dane M Newman, Patrick Sk Leung, Tracy L Putoczki, et al.
Molecular and Cellular Endocrinology|January 16, 2017
STAT3 signaling mediates tumour resistance to EGFR targeted therapeuticsAhmad A Zulkifli, Fiona H Tan, Tracy L Putoczki, et al.
The FEBS Journal|October 27, 2024
The structure of the IL-11 signalling complex provides insight into receptor variants associated with craniosynostosisDarlene D Sentosa, Riley D Metcalfe, Natalie A Sims, et al.
International Journal of Molecular Sciences|March 28, 2024
Identification of Serum Biomarkers to Monitor Therapeutic Response in Intestinal-Type Gastric CancerLaura F Dagley, Jumana Yousef, Adele Preaudet, et al.
Pageof 6